IGHG1+ malignant epithelial Cell-myCAF crosstalk via MIF-CD74/APP-CD74 drives early brain metastasis in NSCLC: Delineated via primary tumor-brain metastasis single-cell and spatial transcriptomics
Cancer Letters · 2026-06 · 647 · 218451
DOI: 10.1016/j.canlet.2026.218451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026-06. Verfasst von Liying Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Shandong University Cancer Center, Shandong University, Jinan, Shandong, China; Department of Radiation Oncology, Shandong Cancer Hospital and Instit…. Hauptthemen laut MEDLINE: Antigens, Differentiation, B-Lymphocyte, Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Department of Science and Technology of Shandong Province, Key Technology Research and Development Program of Shandong Province, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
To investigate the mechanisms of early brain metastasis in non-small cell lung cancer (NSCLC) using spatial multi-omics technology, develop predictive models, and identify potential therapeutic targets. A retrospective analysis was conducted on paraffin samples from 53 NSCLC patients (stages I-IV), including normal lung tissue (NL), primary tumors with/without brain metastasis (PTNBrM/PTBrM), brain metastases (BrM), and normal brain tissue. Integrated single-nucleus RNA sequencing, GeoMx DSP, and CosMx SMI. Augur, pseudo-time, and space communication analysis identified key cells and molecules. ROC and survival analysis evaluated predictive performance. Potential preventive targets screened from the Therapeutic Target Database. snRNA-seq revealed that IGHG1+ malignant epithelial cell (MEC) represent the terminal differentiation state of PTBrM epithelium, showing significant enrichment in EMT pathways. These cells uniquely responded to biological perturbations (NL→PTBrM vs NL→PTNBrM, 0.596 vs 0.000, P = 0.002). Spatial transcriptomics further indicated that IGHG1+ MEC predominantly localized at the invasive front of PTBrM, co-localizing with myofibroblastic cancer-associated fibroblast (myCAF; r = 0.900). Multi-omics demonstrated bidirectional interactions between IGHG1+ MEC and myCAF at PTBrM margins via MIF-CD74/APP-CD74 axes, which were also validated both clinically and in vitro. High CD74 at margins was an independent predictor of brain metastasis (AUC = 0.776; HR = 5.495), linked to shorter brain metastasis-free survival (37 vs 60 months, P < 0.0001). In vivo studies confirmed that the candidate drugs targeting CD74, doxorubicin and milatuzumab, have a tendency to inhibit EMT. IGHG1+ MEC collaborate with myCAF to shape a pro-metastatic microenvironment, with the MIF-CD74/APP-CD74 interaction network serving as a driver of NSCLC brain metastasis. CD74-targeting therapies show promising clinical potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong University Cancer Center, Shandong University, Jinan, Shandong, China; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sc…
- Department of Radiation Oncology, Handan First Hospital, Handan, 056002, Hebei, China.
- Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
- Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong, China; Department of Oncology, The Affiliated Hospital…
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong, China; Department of Graduate, Shandong First Medical U…
Förderung
- Department of Science and Technology of Shandong Province
- Key Technology Research and Development Program of Shandong Province
- Natural Science Foundation of Shandong Province
- National Science and Technology Major Project
- National Natural Science Foundation of China
Zitieren
APA
Yang, L., Yang, H., Zhao, M., Wen, Y., Wu, L., Chen, Q., Cao, F., Zhao, Y., Ye, D., Yuan, M., Yu, J., Sun, X., & Xing, L. (2026). IGHG1+ malignant epithelial Cell-myCAF crosstalk via MIF-CD74/APP-CD74 drives early brain metastasis in NSCLC: Delineated via primary tumor-brain metastasis single-cell and spatial transcriptomics. Cancer Letters, 647, 218451. https://doi.org/10.1016/j.canlet.2026.218451
Vancouver
Yang L, Yang H, Zhao M, Wen Y, Wu L, Chen Q, et al. IGHG1+ malignant epithelial Cell-myCAF crosstalk via MIF-CD74/APP-CD74 drives early brain metastasis in NSCLC: Delineated via primary tumor-brain metastasis single-cell and spatial transcriptomics. Cancer Letters. 2026;647:218451. doi:10.1016/j.canlet.2026.218451
BibTeX
@article{Yang2026,
author = {Yang, Liying and Yang, Hao and Zhao, Miaoqing and Wen, Yinhui and Wu, Li and Chen, Qianhui and Cao, Fanghan and Zhao, Yimin and Ye, Duming and Yuan, Meicheng and Yu, Jinming and Sun, Xiaorong and Xing, Ligang},
title = {IGHG1+ malignant epithelial Cell-myCAF crosstalk via MIF-CD74/APP-CD74 drives early brain metastasis in NSCLC: Delineated via primary tumor-brain metastasis single-cell and spatial transcriptomics},
journal = {Cancer Letters},
year = {2026},
volume = {647},
pages = {218451},
doi = {10.1016/j.canlet.2026.218451}
}
EUVIMED